Mmp-2 Responsive Glycogen-Based Nanoparticles for Codelivery of Hyaluronidase and Doxorubicin to Enhance Tumor Penetration and Chemotherapy Article Swipe

View

Jie Li , Chunhui Tao , Jiamin Xu , Yuhang Xiao , Meiyang Yang , Weijun Chen , Lipeng Qiu ·

YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.2139/ssrn.5139502

Related Topics

Concepts

Doxorubicin Hyaluronidase Matrix metalloproteinase Chemotherapy Penetration (warfare) Glycogen Cancer research Nanoparticle Chemistry Pharmacology Enzyme Medicine Materials science Biochemistry Internal medicine Nanotechnology Engineering Operations research

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.2139/ssrn.5139502
OA Status: green
References: 69
Related Works: 10
OpenAlex ID: https://openalex.org/W4407774032

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4407774032

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.2139/ssrn.5139502

Digital Object Identifier
Title: Mmp-2 Responsive Glycogen-Based Nanoparticles for Codelivery of Hyaluronidase and Doxorubicin to Enhance Tumor Penetration and Chemotherapy

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2025

Year of publication
Publication date: 2025-01-01

Full publication date if available
Authors: Jie Li, Chunhui Tao, Jiamin Xu, Yuhang Xiao, Meiyang Yang, Weijun Chen, Lipeng Qiu

List of authors in order
Landing page: https://doi.org/10.2139/ssrn.5139502

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: green

Open access status per OpenAlex
OA URL: https://doi.org/10.2139/ssrn.5139502

Direct OA link when available
Concepts: Doxorubicin, Hyaluronidase, Matrix metalloproteinase, Chemotherapy, Penetration (warfare), Glycogen, Cancer research, Nanoparticle, Chemistry, Pharmacology, Enzyme, Medicine, Materials science, Biochemistry, Internal medicine, Nanotechnology, Engineering, Operations research

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
References (count): 69

Number of works referenced by this work
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4407774032
doi	https://doi.org/10.2139/ssrn.5139502
ids.doi	https://doi.org/10.2139/ssrn.5139502
ids.openalex	https://openalex.org/W4407774032
fwci	0.0
type	preprint
title	Mmp-2 Responsive Glycogen-Based Nanoparticles for Codelivery of Hyaluronidase and Doxorubicin to Enhance Tumor Penetration and Chemotherapy
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T10063
topics[0].field.id	https://openalex.org/fields/25
topics[0].field.display_name	Materials Science
topics[0].score	0.9998000264167786
topics[0].domain.id	https://openalex.org/domains/3
topics[0].domain.display_name	Physical Sciences
topics[0].subfield.id	https://openalex.org/subfields/2502
topics[0].subfield.display_name	Biomaterials
topics[0].display_name	Nanoparticle-Based Drug Delivery
topics[1].id	https://openalex.org/T10782
topics[1].field.id	https://openalex.org/fields/22
topics[1].field.display_name	Engineering
topics[1].score	0.9995999932289124
topics[1].domain.id	https://openalex.org/domains/3
topics[1].domain.display_name	Physical Sciences
topics[1].subfield.id	https://openalex.org/subfields/2204
topics[1].subfield.display_name	Biomedical Engineering
topics[1].display_name	Nanoplatforms for cancer theranostics
topics[2].id	https://openalex.org/T11419
topics[2].field.id	https://openalex.org/fields/25
topics[2].field.display_name	Materials Science
topics[2].score	0.9994000196456909
topics[2].domain.id	https://openalex.org/domains/3
topics[2].domain.display_name	Physical Sciences
topics[2].subfield.id	https://openalex.org/subfields/2502
topics[2].subfield.display_name	Biomaterials
topics[2].display_name	Supramolecular Self-Assembly in Materials
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2781303535
concepts[0].level	3
concepts[0].score	0.8288909196853638
concepts[0].wikidata	https://www.wikidata.org/wiki/Q18936
concepts[0].display_name	Doxorubicin
concepts[1].id	https://openalex.org/C2780375986
concepts[1].level	3
concepts[1].score	0.6699344515800476
concepts[1].wikidata	https://www.wikidata.org/wiki/Q904015
concepts[1].display_name	Hyaluronidase
concepts[2].id	https://openalex.org/C109523444
concepts[2].level	2
concepts[2].score	0.5650118589401245
concepts[2].wikidata	https://www.wikidata.org/wiki/Q424216
concepts[2].display_name	Matrix metalloproteinase
concepts[3].id	https://openalex.org/C2776694085
concepts[3].level	2
concepts[3].score	0.5593795776367188
concepts[3].wikidata	https://www.wikidata.org/wiki/Q974135
concepts[3].display_name	Chemotherapy
concepts[4].id	https://openalex.org/C80107235
concepts[4].level	2
concepts[4].score	0.5553092360496521
concepts[4].wikidata	https://www.wikidata.org/wiki/Q7162625
concepts[4].display_name	Penetration (warfare)
concepts[5].id	https://openalex.org/C2777499176
concepts[5].level	2
concepts[5].score	0.5191923379898071
concepts[5].wikidata	https://www.wikidata.org/wiki/Q174936
concepts[5].display_name	Glycogen
concepts[6].id	https://openalex.org/C502942594
concepts[6].level	1
concepts[6].score	0.4445019066333771
concepts[6].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[6].display_name	Cancer research
concepts[7].id	https://openalex.org/C155672457
concepts[7].level	2
concepts[7].score	0.4170338213443756
concepts[7].wikidata	https://www.wikidata.org/wiki/Q61231
concepts[7].display_name	Nanoparticle
concepts[8].id	https://openalex.org/C185592680
concepts[8].level	0
concepts[8].score	0.39470964670181274
concepts[8].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[8].display_name	Chemistry
concepts[9].id	https://openalex.org/C98274493
concepts[9].level	1
concepts[9].score	0.3485591411590576
concepts[9].wikidata	https://www.wikidata.org/wiki/Q128406
concepts[9].display_name	Pharmacology
concepts[10].id	https://openalex.org/C181199279
concepts[10].level	2
concepts[10].score	0.3183861970901489
concepts[10].wikidata	https://www.wikidata.org/wiki/Q8047
concepts[10].display_name	Enzyme
concepts[11].id	https://openalex.org/C71924100
concepts[11].level	0
concepts[11].score	0.27495062351226807
concepts[11].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[11].display_name	Medicine
concepts[12].id	https://openalex.org/C192562407
concepts[12].level	0
concepts[12].score	0.25383391976356506
concepts[12].wikidata	https://www.wikidata.org/wiki/Q228736
concepts[12].display_name	Materials science
concepts[13].id	https://openalex.org/C55493867
concepts[13].level	1
concepts[13].score	0.2507660388946533
concepts[13].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[13].display_name	Biochemistry
concepts[14].id	https://openalex.org/C126322002
concepts[14].level	1
concepts[14].score	0.19673284888267517
concepts[14].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[14].display_name	Internal medicine
concepts[15].id	https://openalex.org/C171250308
concepts[15].level	1
concepts[15].score	0.15890410542488098
concepts[15].wikidata	https://www.wikidata.org/wiki/Q11468
concepts[15].display_name	Nanotechnology
concepts[16].id	https://openalex.org/C127413603
concepts[16].level	0
concepts[16].score	0.07564812898635864
concepts[16].wikidata	https://www.wikidata.org/wiki/Q11023
concepts[16].display_name	Engineering
concepts[17].id	https://openalex.org/C42475967
concepts[17].level	1
concepts[17].score	0.0
concepts[17].wikidata	https://www.wikidata.org/wiki/Q194292
concepts[17].display_name	Operations research
keywords[0].id	https://openalex.org/keywords/doxorubicin
keywords[0].score	0.8288909196853638
keywords[0].display_name	Doxorubicin
keywords[1].id	https://openalex.org/keywords/hyaluronidase
keywords[1].score	0.6699344515800476
keywords[1].display_name	Hyaluronidase
keywords[2].id	https://openalex.org/keywords/matrix-metalloproteinase
keywords[2].score	0.5650118589401245
keywords[2].display_name	Matrix metalloproteinase
keywords[3].id	https://openalex.org/keywords/chemotherapy
keywords[3].score	0.5593795776367188
keywords[3].display_name	Chemotherapy
keywords[4].id	https://openalex.org/keywords/penetration
keywords[4].score	0.5553092360496521
keywords[4].display_name	Penetration (warfare)
keywords[5].id	https://openalex.org/keywords/glycogen
keywords[5].score	0.5191923379898071
keywords[5].display_name	Glycogen
keywords[6].id	https://openalex.org/keywords/cancer-research
keywords[6].score	0.4445019066333771
keywords[6].display_name	Cancer research
keywords[7].id	https://openalex.org/keywords/nanoparticle
keywords[7].score	0.4170338213443756
keywords[7].display_name	Nanoparticle
keywords[8].id	https://openalex.org/keywords/chemistry
keywords[8].score	0.39470964670181274
keywords[8].display_name	Chemistry
keywords[9].id	https://openalex.org/keywords/pharmacology
keywords[9].score	0.3485591411590576
keywords[9].display_name	Pharmacology
keywords[10].id	https://openalex.org/keywords/enzyme
keywords[10].score	0.3183861970901489
keywords[10].display_name	Enzyme
keywords[11].id	https://openalex.org/keywords/medicine
keywords[11].score	0.27495062351226807
keywords[11].display_name	Medicine
keywords[12].id	https://openalex.org/keywords/materials-science
keywords[12].score	0.25383391976356506
keywords[12].display_name	Materials science
keywords[13].id	https://openalex.org/keywords/biochemistry
keywords[13].score	0.2507660388946533
keywords[13].display_name	Biochemistry
keywords[14].id	https://openalex.org/keywords/internal-medicine
keywords[14].score	0.19673284888267517
keywords[14].display_name	Internal medicine
keywords[15].id	https://openalex.org/keywords/nanotechnology
keywords[15].score	0.15890410542488098
keywords[15].display_name	Nanotechnology
keywords[16].id	https://openalex.org/keywords/engineering
keywords[16].score	0.07564812898635864
keywords[16].display_name	Engineering
language	en
locations[0].id	doi:10.2139/ssrn.5139502
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210172589
locations[0].source.issn	1556-5068
locations[0].source.type	repository
locations[0].source.is_oa	True
locations[0].source.issn_l	1556-5068
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	SSRN Electronic Journal
locations[0].source.host_organization	https://openalex.org/I1318003438
locations[0].source.host_organization_name	RELX Group (Netherlands)
locations[0].source.host_organization_lineage	https://openalex.org/I1318003438
locations[0].license
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.2139/ssrn.5139502
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5100428313
authorships[0].author.orcid	https://orcid.org/0000-0003-0189-2787
authorships[0].author.display_name	Jie Li
authorships[0].author_position	first
authorships[0].raw_author_name	Jie Li
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5046414762
authorships[1].author.orcid
authorships[1].author.display_name	Chunhui Tao
authorships[1].author_position	middle
authorships[1].raw_author_name	Chunying Tao
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5018026858
authorships[2].author.orcid	https://orcid.org/0000-0002-8342-0275
authorships[2].author.display_name	Jiamin Xu
authorships[2].author_position	middle
authorships[2].raw_author_name	Jiamin Xu
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5013184131
authorships[3].author.orcid	https://orcid.org/0000-0003-1612-0245
authorships[3].author.display_name	Yuhang Xiao
authorships[3].author_position	middle
authorships[3].raw_author_name	Yuhang Xiao
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5066795234
authorships[4].author.orcid
authorships[4].author.display_name	Meiyang Yang
authorships[4].author_position	middle
authorships[4].raw_author_name	Meiyang Yang
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5101919673
authorships[5].author.orcid	https://orcid.org/0000-0001-8927-9738
authorships[5].author.display_name	Weijun Chen
authorships[5].author_position	middle
authorships[5].raw_author_name	Weijun Chen
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5006720191
authorships[6].author.orcid	https://orcid.org/0000-0001-7546-7420
authorships[6].author.display_name	Lipeng Qiu
authorships[6].author_position	last
authorships[6].raw_author_name	Lipeng Qiu
authorships[6].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.2139/ssrn.5139502
open_access.oa_status	green
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Mmp-2 Responsive Glycogen-Based Nanoparticles for Codelivery of Hyaluronidase and Doxorubicin to Enhance Tumor Penetration and Chemotherapy
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T10063
primary_topic.field.id	https://openalex.org/fields/25
primary_topic.field.display_name	Materials Science
primary_topic.score	0.9998000264167786
primary_topic.domain.id	https://openalex.org/domains/3
primary_topic.domain.display_name	Physical Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2502
primary_topic.subfield.display_name	Biomaterials
primary_topic.display_name	Nanoparticle-Based Drug Delivery
related_works	https://openalex.org/W2103258952, https://openalex.org/W2156492564, https://openalex.org/W2115203078, https://openalex.org/W3171281340, https://openalex.org/W4293786923, https://openalex.org/W2886384426, https://openalex.org/W2401171547, https://openalex.org/W2128237198, https://openalex.org/W2328820385, https://openalex.org/W2788918309
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.2139/ssrn.5139502
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210172589
best_oa_location.source.issn	1556-5068
best_oa_location.source.type	repository
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	1556-5068
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	SSRN Electronic Journal
best_oa_location.source.host_organization	https://openalex.org/I1318003438
best_oa_location.source.host_organization_name	RELX Group (Netherlands)
best_oa_location.source.host_organization_lineage	https://openalex.org/I1318003438
best_oa_location.license
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.2139/ssrn.5139502
primary_location.id	doi:10.2139/ssrn.5139502
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210172589
primary_location.source.issn	1556-5068
primary_location.source.type	repository
primary_location.source.is_oa	True
primary_location.source.issn_l	1556-5068
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	SSRN Electronic Journal
primary_location.source.host_organization	https://openalex.org/I1318003438
primary_location.source.host_organization_name	RELX Group (Netherlands)
primary_location.source.host_organization_lineage	https://openalex.org/I1318003438
primary_location.license
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.2139/ssrn.5139502
publication_date	2025-01-01
publication_year	2025
referenced_works	https://openalex.org/W4321793035, https://openalex.org/W4360977235, https://openalex.org/W3080519218, https://openalex.org/W2554773181, https://openalex.org/W2942900492, https://openalex.org/W2799463670, https://openalex.org/W2530625287, https://openalex.org/W3202903686, https://openalex.org/W3136368870, https://openalex.org/W4386564730, https://openalex.org/W2053311966, https://openalex.org/W2082587127, https://openalex.org/W2057632167, https://openalex.org/W3136027982, https://openalex.org/W3138392906, https://openalex.org/W3159078119, https://openalex.org/W3202229075, https://openalex.org/W3203596616, https://openalex.org/W3152730756, https://openalex.org/W2094672113, https://openalex.org/W4281678632, https://openalex.org/W4284961560, https://openalex.org/W3162155403, https://openalex.org/W4200084284, https://openalex.org/W4400254901, https://openalex.org/W4386629877, https://openalex.org/W3126673920, https://openalex.org/W3137752930, https://openalex.org/W2896523722, https://openalex.org/W2766149272, https://openalex.org/W2887832992, https://openalex.org/W2902946041, https://openalex.org/W2593401902, https://openalex.org/W3107343765, https://openalex.org/W3083326915, https://openalex.org/W3118610560, https://openalex.org/W2082046119, https://openalex.org/W2187985754, https://openalex.org/W4214616497, https://openalex.org/W4220724925, https://openalex.org/W4401524736, https://openalex.org/W4401503799, https://openalex.org/W4401298362, https://openalex.org/W2982050130, https://openalex.org/W3049600869, https://openalex.org/W4206348307, https://openalex.org/W3142271733, https://openalex.org/W3123026275, https://openalex.org/W4205619891, https://openalex.org/W4200053732, https://openalex.org/W4205794593, https://openalex.org/W2155897366, https://openalex.org/W2601855629, https://openalex.org/W2282588309, https://openalex.org/W2044736201, https://openalex.org/W2276262061, https://openalex.org/W1996158195, https://openalex.org/W2625669596, https://openalex.org/W2804363103, https://openalex.org/W2963653988, https://openalex.org/W2912665154, https://openalex.org/W4379967145, https://openalex.org/W4312194808, https://openalex.org/W4317435051, https://openalex.org/W2022234371, https://openalex.org/W4390849535, https://openalex.org/W4245955322, https://openalex.org/W2056493684, https://openalex.org/W4225693627
referenced_works_count	69
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	7
citation_normalized_percentile.value	0.03922016
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False